Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

IEX Schedule One Update

6 Jun 2007 17:27

First Derivatives PLC06 June 2007 IEX SCHEDULE ONE-PRE-ADMISSION ANNOUNCEMENT COMPANY NAME: First Derivatives public limited companyCOUNTRY OF INCORPORATION: Northern IrelandCOMPANY ADDRESS: Registered Office: 40 Church Street, Belfast, Co Antrim, BT1 4FRCOMPANY BUSINESS OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGY TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE TWO, PARAGRAPH (J) OF THE IEX RULES: First Derivatives plc provides a range of services and software to the capital markets industry. Our customers includeinvestment banks, hedge funds, Specialised Investment Vehicles and Derivatives Product Companies as well as softwarecompanies selling to these organisations. Our range of services include project management and integration services,outsourced systems development and support, training and the provision of niche trading and risk managementapplications.DETAILS OF SECURITIES TO BE ADMITTED (i.e. where known, number of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares): 12,994,158 Ordinary shares of 0.5 pence eachCAPITAL TO BE RAISED ON ADMISSION: None FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS: Robert David Anderson - Non-executive chairman Brian Gerard Conlon - Managing director Michael George O'Neill - Operations Director Adrian John Toner - Non-executive DirectorPERSON(S) INTERESTED IN 5% OR MORE OF THE ISSUER CAPITAL, EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL BEFORE AND AFTER ADMISSION: Brian Gerard Conlon - 70.1% Michael George O'Neill 8.0%NAMES AND ADDRESSES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE TWO, PARAGRAPH (H) OF THE IEX RULES: NoneANTICIPATED ACCOUNTING REFERENCE DATE: 28 FebruaryEXPECTED ADMISSION DATE: 8 June 2007NAME AND ADDRESS OF IEX ADVISER: Goodbody Corporate Finance, Ballsbridge Park, Ballsbridge, Dublin 4NAME AND ADDRESS OF BROKER:Goodbody Stockbrokers, Ballsbridge Park, Ballsbridge, Dublin 4 DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIESN/ADATE OF NOTIFICATION: 10 May 2007QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING: THE NAME OF THE IEX DESIGNATED MARKET UPON WHICH THE APPLICANT SECURITIES HAVE BEEN TRADED: AIM market of the London Stock Exchange THE DATE FROM WHICH THE APPLICANT SECURITIES HAVE BEEN SO TRADED: 28 March 2002CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORYREQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET: First Derivatives confirms, having made due and careful enquiry, that as at the date of this announcement the Companyhas adhered to the legal and regulatory requirements involved in having its securities traded on the AIM market of theLondon Stock Exchange. AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THE LAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE: www.firstderivatives.comDETAILS OF THE APPLICANT STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTMENT STRATEGYFirst Derivatives plc will continue to pursue its current strategy of maximising shareholder value by growing itsbusiness within each of its 3 main profit centres. Personnel can transfer seamlessly between these centres andopportunities exist for cross-selling services and software. Capital Markets First Derivatives will continue to expand relationships with existing customers and to seek new customers for itsgeneral consulting services. The company has a strong brand and a critical mass of consultants which will allow it tofocus on providing teams of highly skilled consultants on long-term projects or projects with a significant potentialfor recurring revenue. Sales Partnerships First Derivatives operates partnerships with a number of non-competing software vendors, including one with KX Systems(www.kx.com). New opportunities will be sought to expand the portfolio of partners and to increase revenue fromexisting partnerships. These partnerships allow more points of entry for establishing direct relationships withinvestment banking customers. Product Development A number of R&D initiatives are on the verge of commercial exploitation. These are in areas such as algorithmic programtrading, compliance and market data management. A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED: Otherwise than disclosed in the Company public records, there has been no significant change in the financial ortrading position of the Company since 28 February 2007, the end of the last financial year for which audited financialstatements have been published. A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILABLE TO IT OR ITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION: The directors of the Company have no reason to believe that the working capital available to it or its group will be insufficient for at least twelve months from the date of its admission. DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE IEX RULES: NoneA BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT SECURITIES: Following Admission settlement of transactions in the Ordinary Shares may take place within the CREST system ifShareholders so wish. CREST is a voluntary system and holders of Ordinary Shares who wish to receive and retain sharecertificates will be able to do. A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT SECURITIES: Details are contained in the Admission Document available at www.firstderivatives.com INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC: Not applicable A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE A FINANCIAL YEAR END NOT MORE THAN NINE MONTHS PRIOR TO ADMISSION AND FULLY AUDITED INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTS MUST BE PREPARED ACCORDING TO IRISH, UK OR US GAAP OR INTERNATIONAL ACCOUNTING STANDARDS. www.firstderivatives.comTHE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY. None This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.